BOSTON, MA — September 16, 2025 — Leads & Copy — Top biopharmaceutical executives, government officials, academic leaders, and investors will gather at the Boston CEO forum, held at the Mandarin Oriental Hotel, Boston, on October 27-28, 2025. Longwood Healthcare Leaders is hosting the industry meeting with leaders including Marc Casper (Thermo Fisher Scientific), Thomas Schinecker (Roche), Bob Langer (MIT; Moderna), Phil Sharp (MIT; Biogen/Alnylam), Anne Klibanski (Mass General Brigham), Priya Singhal (Biogen), Mathai Mammen (Parabilis Medicines; Johnson & Johnson), and Christoph Westphal (Longwood Fund).
The networking and discussion forum focuses on topics affecting the biopharma ecosystem. Decision makers will discuss issues facing the life sciences ecosystem. Speakers include Maura Healey (Governor, Massachusetts), Dave Moore (Novo Nordisk Inc.), Miguel Fernandez Alcalde (EMD Serono), Tarek Rabah (Otsuka North America), Peter Marks (former Director, CBER, FDA), Marianne De Backer (Vir Bio), Stu Mackey (Daiichi Sankyo), Sally Kornbluth (MIT), Tim Springer (Harvard), Stewart Geary (Eisai), Pushkal Garg (Alnylam), and Ben Ebert (Dana-Farber Cancer Institute).
The forum encourages open dialogue with a peer C-suite audience, generating actionable takeaways and business development opportunities. Discussion topics include accelerating drug discovery and development, patient-centric development, advancing late-stage assets, evaluating investment risk, targeted licensing and acquisitions, navigating partnerships across borders, biopharma pipeline sourcing, R&D collaboration, developing an effective board, managing the runway, positioning for commercial success, adapting to business opportunities in Asia, and ensuring global access.
The agenda is designed to maximize networking opportunities, including luncheons, breakfasts, and a cocktail reception. To learn more, visit www.longwoodhealthcareleaders.com/bostonceo.
Longwood Healthcare Leaders hosts thought leaders, executives, and government officials for quarterly forums to foster collaboration and drive biomedical advancements.
Arielle Jackson, Director, Investor Relations, arielle@longwoodfund.com, 617-351-2590
Source: Longwood Healthcare Leaders
